Whey proteins as stabilizers in amorphous solid dispersions.


Journal

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982

Informations de publication

Date de publication:
01 Feb 2019
Historique:
received: 09 07 2018
revised: 16 11 2018
accepted: 03 12 2018
pubmed: 12 12 2018
medline: 29 5 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Whey proteins are extensively used as nutritional supplements but have so far not been investigated as co-formers for amorphous solid dispersions (ASD) to enhance the solubility and dissolution rate of poorly water soluble drugs. In this study, whey protein isolate (WPI) and whey protein hydrolysate (WPH) were each mixed with three poorly water soluble drugs (indomethacin: IND, carvedilol: CAR and furosemide: FUR) and prepared as ASDs at 50% (w/w) drug loading using vibrational ball milling. Subsequently, solid state characteristics, dissolution rate and physical stability of the obtained samples were analyzed. All ASDs showed a significant increase in their glass transition temperatures, as well as faster dissolution rates and higher apparent solubilities compared to both the respective pure crystalline and amorphous drugs. The saturation solubility of the drugs was increased in the presence of the whey proteins, and the investigated ASDs showed supersaturation by attaining higher drug concentrations compared to the respective saturation solubilities. Upon storage, ASDs containing IND were found to be physically stable for at least 27 months, whereas, ASDs containing CAR or FUR were stable for about 8 months and 17 months, respectively. This was a tremendous increase in physical stability compared to the pure amorphous drugs which recrystallized within less than one week. Overall, WPI and WPH proved to be promising co-formers and amorphous stabilizers in ASD formulations.

Identifiants

pubmed: 30528387
pii: S0928-0987(18)30531-1
doi: 10.1016/j.ejps.2018.12.002
pii:
doi:

Substances chimiques

Adrenergic beta-Antagonists 0
Anti-Inflammatory Agents, Non-Steroidal 0
Diuretics 0
Dosage Forms 0
Excipients 0
Whey Proteins 0
Carvedilol 0K47UL67F2
Furosemide 7LXU5N7ZO5
Indomethacin XXE1CET956

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144-151

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Jaya Mishra (J)

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.

Adam Bohr (A)

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.

Thomas Rades (T)

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark; Department of Pharmacy, Faculty of Science and Engineering, Åbo Akademi University, 20521 Turku, Finland.

Holger Grohganz (H)

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.

Korbinian Löbmann (K)

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark. Electronic address: korbinian.loebmann@sund.ku.dk.

Articles similaires

Humans Chromatography, High Pressure Liquid Acetaminophen COVID-19 SARS-CoV-2
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility
Humans Pain Management Child Fractures, Bone Pain Measurement
Powders Machine Learning Wettability Particle Size Viscosity

Classifications MeSH